ChemicalBook > Product Catalog >Pharmaceutical intermediates >Heterocyclic compound >Pyridine compound >Ethylpyridine >GSK1904529A
GSK1904529A
- CAS No.
- 1089283-49-7
- Chemical Name:
- GSK1904529A
- Synonyms
- CS-29;GSK 4529;GSK1904529A;GSK1904529A, >=98%;GSK1904529A (GSK-4529;IGF-IR, IGF-IIR inhibitor;IGF-1R inhibitor GS1904529A;GSK1904529A ISO 9001:2015 REACH;GSK1904529A;GSK-1904529A;GSK 1904529A;GSK1904529A : IGF-IR, IGF-IIR inhibitor
- CBNumber:
- CB92501005
- Molecular Formula:
- C44H47F2N9O5S
- Molecular Weight:
- 851.96
- MOL File:
- 1089283-49-7.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/2 8:55:41
GSK1904529A Preparation Products And Raw materials
Global( 108)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
Capot Chemical Co.,Ltd. | 571-85586718 +8613336195806 | China | 29798 | 60 | Inquiry |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 | China | 49391 | 58 | Inquiry |
Shaanxi Dideu Medichem Co. Ltd | +86-029-89586680 +86-18192503167 | China | 8853 | 58 | Inquiry |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | China | 10522 | 58 | Inquiry |
InvivoChem | +1-708-310-1919 +1-13798911105 | United States | 6393 | 58 | Inquiry |
TargetMol Chemicals Inc. | +1-781-999-5354 | United States | 19973 | 58 | Inquiry |
Jilin Chinese Academy of Sciences-yanshen Technology | +undefined18143011203 | China | 42057 | 58 | Inquiry |
Aladdin Scientific | +1-+1(833)-552-7181 | United States | 57511 | 58 | Inquiry |
1089283-49-7(GSK1904529A)Related Search:
chevron_left
1of2
chevron_right
GSK 4529
GSK1904529A
GSK1904529A : IGF-IR, IGF-IIR inhibitor
N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide
N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide GSK 1904529A
GSK1904529A, >=98%
IGF-IR, IGF-IIR inhibitor
N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]
CS-29
GSK1904529A;GSK-1904529A;GSK 1904529A
Benzamide, N-(2,6-difluorophenyl)-5-[3-[2-[[5-ethyl-2-methoxy-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-methoxy-
GSK1904529A ISO 9001:2015 REACH
GSK1904529A (GSK-4529
N-(2,6-Difluorophenyl)-5-(3-(2-((5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
IGF-1R inhibitor GS1904529A
1089283-49-7
C44H47F2N9O5S
Inhibitors